Recent News for CUE - Cue Biopharma, Inc.

Date Title
Apr 9 We're Not Very Worried About Cue Biopharma's (NASDAQ:CUE) Cash Burn Rate
Mar 17 Cue Biopharma, Inc. 2021 Q4 - Results - Earnings Call Presentation
Mar 17 Cue Biopharma, Inc. (CUE) CEO Daniel Passeri on Q4 2020 Results - Earnings Call Transcript
Mar 16 Cue Biopharma EPS beats by $0.03, misses on revenue
Mar 16 Cue Biopharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
Mar 15 Cue Biopharma to Present Corporate Overview and Clinical Progress at the Upcoming Oppenheimer 31st Annual Healthcare Conference
Mar 14 Week Ahead In Biotech (March 14-20): Update On Fibrogen-AstraZeneca's Anemia Drug, Earnings and Presentations
Mar 9 Cue Biopharma to Host Business Update Call and Webcast
Mar 1 Cue Biopharma to Present at the Cowen 41st Annual Health Care Conference
Feb 25 Cue Biopharma Enhances Scientific Advisory Board with Appointments of Immunology and Immunotherapy Experts Dr. Abul K. Abbas and Dr. Michael Kalos
Feb 23 What Is The Ownership Structure Like For Cue Biopharma, Inc. (NASDAQ:CUE)?
Feb 22 Cue Biopharma to Present at the 7th Annual Immuno-Oncology 360° Conference
Feb 17 Cue Biopharma Announces Appointment of Matteo Levisetti, M.D. as Senior Vice President of Clinical Development
Feb 8 Cue Biopharma Initiates Patient Dosing in Phase 1 Study of CUE-101 in Combination with KEYTRUDA® (pembrolizumab) as First-line Treatment for HPV+ Recurrent/Metastatic Head and Neck Cancer
Jan 29 7 Stocks With Insider Buying This Week Worth A Look
Jan 9 How Much Are Cue Biopharma, Inc. (NASDAQ:CUE) Insiders Spending On Buying Shares?
Jan 7 Cue Biopharma: CUE-101's Phase 1 Promising Progress, 1 New IND Expected, Funding Until Q2 2022
Dec 16 Is CUE A Good Stock To Buy Now?
Dec 7 Do Options Traders Know Something About Cue Biopharma (CUE) Stock We Don't?
Dec 1 10 Health Care Stocks With Unusual Options Alerts In Today's Session
Nov 25 News Flash: Analysts Just Made A Substantial Upgrade To Their Cue Biopharma, Inc. (NASDAQ:CUE) Forecasts
Nov 24 Benzinga's Top Upgrades, Downgrades For November 24, 2020
Nov 23 Cue Biopharma to Present at the Piper Sandler 32nd Annual Healthcare Conference
Nov 20 Cue Biopharma (CUE) Investor Presentation - Slideshow
Nov 19 Cue Biopharma Extends Research Collaboration for the Development of Immuno-STAT Biologics for the Treatment of Defined Autoimmune Diseases with Merck
Back to the Main CUE Page...